245 related articles for article (PubMed ID: 35122041)
1. Aldolase B suppresses hepatocellular carcinogenesis by inhibiting G6PD and pentose phosphate pathways.
Li M; He X; Guo W; Yu H; Zhang S; Wang N; Liu G; Sa R; Shen X; Jiang Y; Tang Y; Zhuo Y; Yin C; Tu Q; Li N; Nie X; Li Y; Hu Z; Zhu H; Ding J; Li Z; Liu T; Zhang F; Zhou H; Li S; Yue J; Yan Z; Cheng S; Tao Y; Yin H
Nat Cancer; 2020 Jul; 1(7):735-747. PubMed ID: 35122041
[TBL] [Abstract][Full Text] [Related]
2. Fructose-1,6-Bisphosphate Aldolase B Depletion Promotes Hepatocellular Carcinogenesis Through Activating Insulin Receptor Signaling and Lipogenesis.
Liu G; Wang N; Zhang C; Li M; He X; Yin C; Tu Q; Shen X; Zhang L; Lv J; Wang Y; Jiang H; Chen S; Li N; Tao Y; Yin H
Hepatology; 2021 Dec; 74(6):3037-3055. PubMed ID: 34292642
[TBL] [Abstract][Full Text] [Related]
3. Loss of hepatic aldolase B activates Akt and promotes hepatocellular carcinogenesis by destabilizing the Aldob/Akt/PP2A protein complex.
He X; Li M; Yu H; Liu G; Wang N; Yin C; Tu Q; Narla G; Tao Y; Cheng S; Yin H
PLoS Biol; 2020 Dec; 18(12):e3000803. PubMed ID: 33275593
[TBL] [Abstract][Full Text] [Related]
4. Transcription Factor YY1 Promotes Cell Proliferation by Directly Activating the Pentose Phosphate Pathway.
Wu S; Wang H; Li Y; Xie Y; Huang C; Zhao H; Miyagishi M; Kasim V
Cancer Res; 2018 Aug; 78(16):4549-4562. PubMed ID: 29921695
[TBL] [Abstract][Full Text] [Related]
5. Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis.
Kowalik MA; Guzzo G; Morandi A; Perra A; Menegon S; Masgras I; Trevisan E; Angioni MM; Fornari F; Quagliata L; Ledda-Columbano GM; Gramantieri L; Terracciano L; Giordano S; Chiarugi P; Rasola A; Columbano A
Oncotarget; 2016 May; 7(22):32375-93. PubMed ID: 27070090
[TBL] [Abstract][Full Text] [Related]
6. Aldolase B inhibits metastasis through Ten-Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinoma.
Tao QF; Yuan SX; Yang F; Yang S; Yang Y; Yuan JH; Wang ZG; Xu QG; Lin KY; Cai J; Yu J; Huang WL; Teng XL; Zhou CC; Wang F; Sun SH; Zhou WP
Mol Cancer; 2015 Sep; 14():170. PubMed ID: 26376879
[TBL] [Abstract][Full Text] [Related]
7. ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.
Yin X; Tang B; Li JH; Wang Y; Zhang L; Xie XY; Zhang BH; Qiu SJ; Wu WZ; Ren ZG
J Exp Clin Cancer Res; 2017 Nov; 36(1):166. PubMed ID: 29169374
[TBL] [Abstract][Full Text] [Related]
8. Metabolic classification suggests the GLUT1/ALDOB/G6PD axis as a therapeutic target in chemotherapy-resistant pancreatic cancer.
Li Y; Tang S; Shi X; Lv J; Wu X; Zhang Y; Wang H; He J; Zhu Y; Ju Y; Zhang Y; Guo S; Yang W; Yin H; Chen L; Gao D; Jin G
Cell Rep Med; 2023 Sep; 4(9):101162. PubMed ID: 37597521
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of the glycolytic enzymes aldolase B and type II hexokinase in hepatocellular carcinoma are predictive markers for advanced stage, early recurrence and poor prognosis.
Peng SY; Lai PL; Pan HW; Hsiao LP; Hsu HC
Oncol Rep; 2008 Apr; 19(4):1045-53. PubMed ID: 18357395
[TBL] [Abstract][Full Text] [Related]
10. PBX3 promotes pentose phosphate pathway and colorectal cancer progression by enhancing G6PD expression.
Luo X; Wei M; Li W; Zhao H; Kasim V; Wu S
Int J Biol Sci; 2023; 19(14):4525-4538. PubMed ID: 37781025
[TBL] [Abstract][Full Text] [Related]
11. PTEN antagonises Tcl1/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesis.
Hong X; Song R; Song H; Zheng T; Wang J; Liang Y; Qi S; Lu Z; Song X; Jiang H; Liu L; Zhang Z
Gut; 2014 Oct; 63(10):1635-47. PubMed ID: 24352616
[TBL] [Abstract][Full Text] [Related]
12. The role of miR-122 in the dysregulation of glucose-6-phosphate dehydrogenase (G6PD) expression in hepatocellular cancer.
Barajas JM; Reyes R; Guerrero MJ; Jacob ST; Motiwala T; Ghoshal K
Sci Rep; 2018 Jun; 8(1):9105. PubMed ID: 29904144
[TBL] [Abstract][Full Text] [Related]
13. Elevated G6PD expression contributes to migration and invasion of hepatocellular carcinoma cells by inducing epithelial-mesenchymal transition.
Lu M; Lu L; Dong Q; Yu G; Chen J; Qin L; Wang L; Zhu W; Jia H
Acta Biochim Biophys Sin (Shanghai); 2018 Apr; 50(4):370-380. PubMed ID: 29471502
[TBL] [Abstract][Full Text] [Related]
14. G6PD inhibits ferroptosis in hepatocellular carcinoma by targeting cytochrome P450 oxidoreductase.
Cao F; Luo A; Yang C
Cell Signal; 2021 Nov; 87():110098. PubMed ID: 34325001
[TBL] [Abstract][Full Text] [Related]
15. Pan-cancer analysis of G6PD carcinogenesis in human tumors.
Liu B; Fu X; Du Y; Feng Z; Chen R; Liu X; Yu F; Zhou G; Ba Y
Carcinogenesis; 2023 Aug; 44(6):525-534. PubMed ID: 37335542
[TBL] [Abstract][Full Text] [Related]
16. BAG3 elevation inhibits cell proliferation via direct interaction with G6PD in hepatocellular carcinomas.
Kong DH; Li S; Du ZX; Liu C; Liu BQ; Li C; Zong ZH; Wang HQ
Oncotarget; 2016 Jan; 7(1):700-11. PubMed ID: 26621836
[TBL] [Abstract][Full Text] [Related]
17. ALDOB/KAT2A interactions epigenetically modulate TGF-β expression and T cell functions in hepatocellular carcinogenesis.
Yin C; Zhang C; Wang Y; Liu G; Wang N; Liang N; Zhang L; Tu Q; Lv J; Jiang H; Ma H; Du C; Li M; He X; Chen S; Guo J; Li S; Qin J; Li N; Tao Y; Yin H
Hepatology; 2023 Dec; ():. PubMed ID: 38051951
[TBL] [Abstract][Full Text] [Related]
18. NeuroD1 promotes tumor cell proliferation and tumorigenesis by directly activating the pentose phosphate pathway in colorectal carcinoma.
Li Z; He Y; Li Y; Li J; Zhao H; Song G; Miyagishi M; Wu S; Kasim V
Oncogene; 2021 Dec; 40(50):6736-6747. PubMed ID: 34657129
[TBL] [Abstract][Full Text] [Related]
19. Estradiol promotes pentose phosphate pathway addiction and cell survival via reactivation of Akt in mTORC1 hyperactive cells.
Sun Y; Gu X; Zhang E; Park MA; Pereira AM; Wang S; Morrison T; Li C; Blenis J; Gerbaudo VH; Henske EP; Yu JJ
Cell Death Dis; 2014 May; 5(5):e1231. PubMed ID: 24832603
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of ribosomal RNA processing 15 Homolog (RRP15), which is overexpressed in hepatocellular carcinoma, suppresses tumour growth via induction of senescence and apoptosis.
Zhao D; Qian L; Zhuang D; Wang L; Cao Y; Zhou F; Zhang S; Liu Y; Liang Y; Zhang W; Kang W; Zhang M; Wang Y; Zhang F; Zhang W; Xiao J; Xu G; Lv Y; Zou X; Zhuge Y; Zhang B
Cancer Lett; 2021 Oct; 519():315-327. PubMed ID: 34343634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
